Diversifying by Sector: 20 High-Quality Attractive Dividend Growth Stocks Rated A- Or Better (Part 2B)

Introduction This current series of articles could be summarized as a review of ways to construct and diversify a common stock portfolio.  In part 1 found here I discussed various viewpoints on how many stocks a portfolio should hold.  In Part 2A found here I presented and discussed Peter Lynch’s 6 general categories of stocks.  In Read more about Diversifying by Sector: 20 High-Quality Attractive Dividend Growth Stocks Rated A- Or Better (Part 2B)[…]

A Comprehensive Look At Dividend Growth Stock Valuations Sector By Sector: Part 2

Introduction

Finding attractively valued dividend growth stocks is getting harder and harder to do.  The overall market has been on a relentless advance for many years now, and high quality dividend paying growth stocks have been leaders.  Consequently, valuations have become extended beyond historical norms and I contend prudence.  Nevertheless, there are attractive dividend growth stocks available if you’re willing to look hard enough.

[…]

Please follow and like us:

5 Attractive Biotechnology Stocks for Healthy Long-term Returns

Introduction

I am a fervent believer that investors are best served by investing towards a specific investment objective that suits their own unique goals, objectives and risk tolerance.  In other words, investing is not always trying to get the highest possible total returns.  If that were true, no one would have ever invested in bonds, CDs or other fixed income instruments.

[…]

Please follow and like us:

Amgen’s Dividend Policy Has Ignited Their Stock

Founded in 1980, Amgen (AMGN) is the world’s largest biotechnology company with a current market cap of just under $68 billion.  However, in spite of its already large size, we believe that Amgen has ample room to continue growing their earnings at above-average rates into the foreseeable future.  Our optimism for future growth is predicated Read more about Amgen’s Dividend Policy Has Ignited Their Stock[…]

Five Healthy Dividend Growth Stocks to Cure What Ails Your Portfolio

These five above-average growing opportunities in the healthcare sector provide dividend growth investors potential alternatives to the traditional large-cap pharmaceuticals. This is a high quality group of healthcare companies that possess above-average growth potential plus an above-average dividend yield that is expected to grow at above-average future rates. Consequently, we believe these candidates offer the Read more about Five Healthy Dividend Growth Stocks to Cure What Ails Your Portfolio[…]